Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHA2 | P29317 | 2/20 | 0.50 |
| ▸ | KDM1A | O60341 | 3/20 | 0.47 |
| ▸ | CALCRL | Q16602 | 4/20 | 0.47 |
| ▸ | CAPN1 | P07384 | 2/20 | 0.45 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | KDM5A | P29375 | 1/20 | 0.45 |
| ▸ | KDM1B | Q8NB78 | 1/20 | 0.45 |
| ▸ | NPY2R | P49146 | 5/20 | 0.43 |
| ▸ | NPY4R | P50391 | 5/20 | 0.43 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.43 |
| ▸ | NPY1R | P25929 | 4/20 | 0.43 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29611345 | 0.96 | EPHA2 (0.50) | EPHA2KDM1ACALCRLMAOBKDM5A | |
| SCHEMBL29611724 | 0.95 | KDM1A (0.47) | EPHA2KDM1ACAPN1MAOBKDM5A | |
| SCHEMBL29612007 | 0.91 | MAPK8 (0.47) | EPHA2KDM1AMAOBKDM5AKDM1B | |
| SCHEMBL29611470 | 0.86 | MAPK8 (0.48) | EPHA2CALCRLCAPN1 | |
| SCHEMBL29612000 | 0.86 | CAPN1 (0.48) | KDM1ACALCRLCAPN1 | |
| SCHEMBL30980069 | 0.85 | KDM1A (0.53) | EPHA2KDM1AMAOBKDM5AKDM1B | |
| SCHEMBL31665979 | 0.84 | EPHA2 (0.47) | EPHA2KDM1ACALCRLNPY2RNPY4R | |
| SCHEMBL31573966 | 0.84 | MAPK8 (0.48) | EPHA2NPY2RNPY4RNPY5RNPY1R | |
| SCHEMBL29886912 | 0.84 | OPRM1 (0.46) | EPHA2KDM1AOPRM1OPRK1 | |
| SCHEMBL30571159 | 0.83 | MAPK8 (0.51) | EPHA2NPY2RNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2025-09-23 | — | — | US | disclosed |
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2022-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220183950-A1 | COMPOUNDS USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN, HAIR, NAILS AND/OR MUCOUS MEMBRANES | TYR, TELO2, MTX2 | EPHA2 3219/4885KDM1A 1879/4885CALCRL 3281/4885 |
| US-12419824-B2 | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | TYR, TELO2, MTX2 | EPHA2 3219/4885KDM1A 1879/4885CALCRL 3281/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.